Sodium Salicylate

CAS : 54-21-7

Ref. 3D-FS157080

Informations sur le produit

• Nom: Sodium Salicylate
• Synonymes: 2-Hydroxybenzoic acid monosodium salt, Alysine, Aroall, Benzoic acid, 2-hydroxy-, sodium salt (1:1), Camporisin, Clin, Enterosalicyl, Enterosalil, Entrosalyl, Glutosalyl, Idocyl, Kerasalicyl, Kerosal, Magsalyl, Monosodium salicylate, NaSal 31821-45, Nadisal, Natriumsalicylat, Neo-Salicyl, Salicilato De Sodio, Salicylate de sodium, Salicylate, Sodium, Salicylic acid sodium salt, Salicylic acid, monosodium salt, Saliject, Salisod, Salsonin, Sodium 2-hydroxybenzoate, Sodium o-hydroxybenzoate, Sodium salicylate (NaO3C7H5), Sodium salicylate (NaO₃C₇H₅), o-Hydroxybenzoic acid monosodium salt, o-Hydroxybenzoic acid, sodium salt, Sodium Salicylate/Salicylic acid sodium salt, salicylic acid sodium, Sodium sallicylate, Salicylic acid, sodium saltSodium, 2-Hydroxybenzoic acid sodium salt, Benzoic acid, 2-hydroxy-, monosodium salt, o-hydroxybenzoic sodium salt, sodium salicylate usp

Description

Sodium salicylate is a nonsteroidal anti-inflammatory drug that is used to treat inflammatory bowel disease. It has been shown to inhibit leukemia inhibitory factor (LIF) and nf-κb binding activity, which leads to the suppression of inflammation and cancer. Sodium salicylate also binds to DNA, inhibiting dna binding activity and preventing transcription. This drug also inhibits mitochondrial membrane potential as well as signal pathways, which may lead to apoptosis. Sodium salicylate has been shown to have an anti-inflammatory effect by inhibiting the synthesis of proinflammatory proteins such as COX-2, prostaglandins, nitric oxide synthase, and inducible nitric oxide synthase. It also has a hypoglycemic effect.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 160.1 g/mol
• Formule: C₇H₅NaO₃
• Degré de pureté: Min. 95%
• Couleur/Forme: White Clear Liquid